[ Price : $8.95]
FDA tells a Texas federal court it needs until 2076 to respond to a Public Health and Medical Professionals for Transparency reque...[ Price : $8.95]
FDA says AB Science can resume enrollment of ALS patients in a Phase 3 study of masitinib.[ Price : $8.95]
FDA grants fast track designation to a Zentalis investigative drug for uterine serous carcinoma.[ Price : $8.95]
The Alzheimers Association and other stakeholders are launching a national registry for Alzheimers diagnostic and treatment inform...[ Price : $8.95]
Two Wiley Rein attorneys suggest ways companies could approach the new FDA section 510(j)(3) drug reporting requirement.[ Price : $8.95]
SterRx recalls 240 lots of various drug products within their expiry period due to equipment and process issues that could lead to...[ Price : $8.95]
FDA clears an Avinger 510(k) for a new clinical indication for the Pantheris image-guided atherectomy system treating in-stent re...[ Price : $8.95]
FDA qualifies the MED Institutes medical device development tool for virtual MRI safety evaluations of patients with implanted med...